Quick answers
- What is Aloprim?
- Aloprim is a brand name of Allopurinol, a prescription medicine. The FDA NDC Directory lists 1 Aloprim product in 1 strength and form.
- Who makes Aloprim?
- Mylan holds the FDA application for Aloprim (NDA020298, approved May 17, 1996).
- Is there a generic or store brand of Aloprim?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Aloprim product, 3 of them generic. Ask your pharmacist whether one is right for you.
- Has Aloprim been recalled?
- FDA enforcement reports list 1 recall of Aloprim products; the newest started May 5, 2020. A recall usually concerns specific lots, not every product.
What Aloprim is
Each Aloprim product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Allopurinol · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| allopurinol sodium 500 mg/25 mL injection, powder, lyophilized, for solution (intravenous) | Aloprim | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Allopurinol →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA020298 | Mylan | May 17, 1996 | 1 |
Companies that list Aloprim
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Aloprim products.
- Mylan Institutional LLC1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
May 5, 2020 · Class II · Terminated · D-1271-2020
Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50 — Mylan Institutional LLC
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.